These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16600251)

  • 21. Antithrombotic drugs in the primary medical management of intermittent claudication: a meta-analysis.
    Girolami B; Bernardi E; Prins MH; ten Cate JW; Prandoni P; Hettiarachchi R; Marras E; Stefani PM; Girolami A; Büller HR
    Thromb Haemost; 1999 May; 81(5):715-22. PubMed ID: 10365743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tibetan formulas as pleiotropic signatures--application of network medicines in multimorbidity].
    Schwabl H; Vennos C; Saller R
    Forsch Komplementmed; 2013; 20 Suppl 2():35-40. PubMed ID: 23860113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-converting enzyme inhibitors for intermittent claudication associated with peripheral arterial disease.
    Hunter MR; Cahoon WD; Lowe DK
    Ann Pharmacother; 2013 Nov; 47(11):1552-7. PubMed ID: 24285767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is gingko biloba more effective than placebo for the treatment of intermittent claudication?
    Reust CE; Stevermer JJ
    J Fam Pract; 2000 Jul; 49(7):657. PubMed ID: 10923580
    [No Abstract]   [Full Text] [Related]  

  • 25. Editor's choice--The effect of supervision on walking distance in patients with intermittent claudication: a meta-analysis.
    Gommans LN; Saarloos R; Scheltinga MR; Houterman S; de Bie RA; Fokkenrood HJ; Teijink JA
    Eur J Vasc Endovasc Surg; 2014 Aug; 48(2):169-84. PubMed ID: 24928167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Periodontitis from a systemic point of view: an advanced treatment concept with Padma Circosan].
    Müller W
    Forsch Komplementmed; 2013; 20 Suppl 2():31-2. PubMed ID: 23860111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E; Bahnini A; Mouren X; Gamand S
    Int Angiol; 2001 Mar; 20(1):58-65. PubMed ID: 11342997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized clinical trial of angiotensin-converting enzyme inhibitor, ramipril, in patients with intermittent claudication.
    Shahin Y; Cockcroft JR; Chetter IC
    Br J Surg; 2013 Aug; 100(9):1154-63. PubMed ID: 23842829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid foot and calf compression increases walking distance in patients with intermittent claudication: results of a randomized study.
    Ramaswami G; D'Ayala M; Hollier LH; Deutsch R; McElhinney AJ
    J Vasc Surg; 2005 May; 41(5):794-801. PubMed ID: 15886663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PADMA-28, a Tibetan herbal preparation is an inhibitor of inflammatory cytokine production.
    Barak V; Kalickman I; Halperin T; Birkenfeld S; Ginsburg I
    Eur Cytokine Netw; 2004; 15(3):203-9. PubMed ID: 15542444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cilostazol: new drug. Intermittent claudication: too little efficacy, too many risks.
    Prescrire Int; 2009 Apr; 18(100):56-9. PubMed ID: 19585717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up.
    Delis KT; Nicolaides AN; Wolfe JH; Stansby G
    J Vasc Surg; 2000 Apr; 31(4):650-61. PubMed ID: 10753272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New approaches to elucidate the activities of botanical multi-component mixtures].
    Gostner JM; Gruber P; Becker K; Naschberger M; Uberall F
    Forsch Komplementmed; 2013; 20 Suppl 2():41-4. PubMed ID: 23860114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral arterial occlusive disease: conservative treatment of intermittent claudication.
    Kriessmann A
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S72-4. PubMed ID: 1369724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intermittent claudication and beta-blockaders. An unfortunate combination?].
    Andreassen AK; Gullestad L; Bjørnerheim R; Forfang K; Kjekshus J
    Tidsskr Nor Laegeforen; 1995 Feb; 115(6):725-8. PubMed ID: 7900137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti- and pro-oxidative properties of PADMA 28, a Tibetan herbal formulation.
    Suter M; Richter C
    Redox Rep; 2000; 5(1):17-22. PubMed ID: 10905539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Padma 28 in cytostatic-induced dysesthesia and edema of the hands--a case from practice].
    Kneip B
    Forsch Komplementmed; 2013; 20 Suppl 2():33-4. PubMed ID: 23860112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiproliferative properties of Padma Lax and its components ginger and elecampane.
    Hofbauer S; Kainz V; Golser L; Klappacher M; Kiesslich T; Heidegger W; Krammer B; Hermann A; Weiger TM
    Forsch Komplementmed; 2006 Feb; 13 Suppl 1():18-22. PubMed ID: 16582559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tibetan Herbal Tea Agar-35 Reduces Negative Affect and Anxiety: A Placebo-Controlled Pilot Study.
    Martin TJ; Mist S; Lektsok T; Trent NL
    Explore (NY); 2017; 13(6):367-370. PubMed ID: 28967627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apoptosis induced by the Tibetan herbal remedy PADMA 28 in the T cell-derived lymphocytic leukaemia cell line CEM-C7H2.
    Jenny M; Schwaiger W; Bernhard D; Wrulich OA; Cosaceanu D; Fuchs D; Ueberall F
    J Carcinog; 2005 Sep; 4():15. PubMed ID: 16138918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.